Cite
HARVARD Citation
Gärtner, J. et al. (2022). 113 Benefit-risk of ofatumumab in treatment-naïve early relapsing multiple sclerosis patients. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A136. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gärtner, J. et al. (2022). 113 Benefit-risk of ofatumumab in treatment-naïve early relapsing multiple sclerosis patients. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A136. [Online].